Atarabio
Biotechnology · Cell & Gene Therapy
Overview
Atara Biotherapeutics is a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune, and viral diseases.
Official records
Funding and backers
Team
1001-5000
employees, estimated range
Backers
3
Kleiner Perkins, DAG Ventures
Momentum
0/100
no fresh signals
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
2018
Founded
Backed byfrom the funds' portfolios and accelerator catalogs
Kleiner Perkins 
DAG Ventures 
EcoR1 Capital Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Cancer immunotherapy that turns cancer cells into biofactories minting their own destruction.
At CellVax Therapeutics, we are developing the Next Generation of Personalized Immunotherapy.
Next generation immunotherapies for hard-to-treat cancers that are allogeneic and switchable.
T-CURX develops a new generation of T cells for personalized cancer immunotherapy, built on a proprietary platform that overcome challenges…
Invest in cutting-edge immunotherapy solutions targeting cancers and rheumatic diseases.
Pioneering Cell Therapies for the Central Nervous System. We are a Salt Lake City-based biotechnology company developing novel macrophage…
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
Shared investors